2691 related articles for article (PubMed ID: 10344756)
1. Activated Ki-Ras suppresses 12-O-tetradecanoylphorbol-13-acetate-induced activation of the c-Jun NH2-terminal kinase pathway in human colon cancer cells.
Okumura K; Shirasawa S; Nishioka M; Sasazuki T
Cancer Res; 1999 May; 59(10):2445-50. PubMed ID: 10344756
[TBL] [Abstract][Full Text] [Related]
2. Suppression of serum-induced c-jun expression by activated Ki-ras in human colon cancer cells.
Furuse M; Shirasawa S; Okumura K; Ohmori M; Sasazuki T
Jpn J Hum Genet; 1997 Sep; 42(3):409-16. PubMed ID: 12503187
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of T lymphocyte activation by cAMP is associated with down-regulation of two parallel mitogen-activated protein kinase pathways, the extracellular signal-related kinase and c-Jun N-terminal kinase.
Tamir A; Granot Y; Isakov N
J Immunol; 1996 Aug; 157(4):1514-22. PubMed ID: 8759733
[TBL] [Abstract][Full Text] [Related]
4. Multiple signaling pathways for the activation of JNK in mast cells: involvement of Bruton's tyrosine kinase, protein kinase C, and JNK kinases, SEK1 and MKK7.
Kawakami Y; Hartman SE; Holland PM; Cooper JA; Kawakami T
J Immunol; 1998 Aug; 161(4):1795-802. PubMed ID: 9712046
[TBL] [Abstract][Full Text] [Related]
5. Stimulation of Jun N-terminal kinase (JNK) by gonadotropin-releasing hormone in pituitary alpha T3-1 cell line is mediated by protein kinase C, c-Src, and CDC42.
Levi NL; Hanoch T; Benard O; Rozenblat M; Harris D; Reiss N; Naor Z; Seger R
Mol Endocrinol; 1998 Jun; 12(6):815-24. PubMed ID: 9626657
[TBL] [Abstract][Full Text] [Related]
6. Activated Ki-ras enhances sensitivity of ceramide-induced apoptosis without c-Jun NH2-terminal kinase/stress-activated protein kinase or extracellular signal-regulated kinase activation in human colon cancer cells.
Ohmori M; Shirasawa S; Furuse M; Okumura K; Sasazuki T
Cancer Res; 1997 Nov; 57(21):4714-7. PubMed ID: 9354428
[TBL] [Abstract][Full Text] [Related]
7. FGF-2 and TPA induce matrix metalloproteinase-9 secretion in MCF-7 cells through PKC activation of the Ras/ERK pathway.
Liu JF; Crépin M; Liu JM; Barritault D; Ledoux D
Biochem Biophys Res Commun; 2002 May; 293(4):1174-82. PubMed ID: 12054499
[TBL] [Abstract][Full Text] [Related]
8. CGP 41251 and tamoxifen selectively inhibit mitogen-activated protein kinase activation and c-Fos phosphoprotein induction by substance P in human astrocytoma cells.
Luo W; Sharif TR; Houghton PJ; Sharif M
Cell Growth Differ; 1997 Nov; 8(11):1225-40. PubMed ID: 9372245
[TBL] [Abstract][Full Text] [Related]
9. Inhibition by dexamethasone of antigen-induced c-Jun N-terminal kinase activation in rat basophilic leukemia cells.
Hirasawa N; Sato Y; Fujita Y; Mue S; Ohuchi K
J Immunol; 1998 Nov; 161(9):4939-43. PubMed ID: 9794429
[TBL] [Abstract][Full Text] [Related]
10. VEGF activates protein kinase C-dependent, but Ras-independent Raf-MEK-MAP kinase pathway for DNA synthesis in primary endothelial cells.
Takahashi T; Ueno H; Shibuya M
Oncogene; 1999 Apr; 18(13):2221-30. PubMed ID: 10327068
[TBL] [Abstract][Full Text] [Related]
11. Regulation of hairy-cell survival through constitutive activation of mitogen-activated protein kinase pathways.
Kamiguti AS; Harris RJ; Slupsky JR; Baker PK; Cawley JC; Zuzel M
Oncogene; 2003 Apr; 22(15):2272-84. PubMed ID: 12700663
[TBL] [Abstract][Full Text] [Related]
12. ERK signaling pathway is involved in p15INK4b/p16INK4a expression and HepG2 growth inhibition triggered by TPA and Saikosaponin a.
Wen-Sheng W
Oncogene; 2003 Feb; 22(7):955-63. PubMed ID: 12592382
[TBL] [Abstract][Full Text] [Related]
13. Novel roles of specific isoforms of protein kinase C in activation of the c-fos serum response element.
Soh JW; Lee EH; Prywes R; Weinstein IB
Mol Cell Biol; 1999 Feb; 19(2):1313-24. PubMed ID: 9891065
[TBL] [Abstract][Full Text] [Related]
14. Protein kinase C alpha trigger Ras and Raf-independent MEK/ERK activation for TPA-induced growth inhibition of human hepatoma cell HepG2.
Wen-Sheng W
Cancer Lett; 2006 Jul; 239(1):27-35. PubMed ID: 16169661
[TBL] [Abstract][Full Text] [Related]
15. Differential contribution of the ERK and JNK mitogen-activated protein kinase cascades to Ras transformation of HT1080 fibrosarcoma and DLD-1 colon carcinoma cells.
Plattner R; Gupta S; Khosravi-Far R; Sato KY; Perucho M; Der CJ; Stanbridge EJ
Oncogene; 1999 Mar; 18(10):1807-17. PubMed ID: 10086335
[TBL] [Abstract][Full Text] [Related]
16. A protein kinase C-independent pathway leading to c-Jun-dependent expression of 100-kDa Ras GTPase-activating protein in JEG-3 human choriocarcinoma cells.
Ye F; Bourgeade MF; Cayre YE; Thang MN
Eur J Biochem; 2000 Mar; 267(6):1589-97. PubMed ID: 10712588
[TBL] [Abstract][Full Text] [Related]
17. Involvement of both extracellular signal-regulated kinase and c-jun N-terminal kinase pathways in the 12-O-tetradecanoylphorbol-13-acetate-induced upregulation of p21(Cip1) in colon cancer cells.
Lin SY; Liang YC; Ho YS; Tsai SH; Pan S; Lee WS
Mol Carcinog; 2002 Sep; 35(1):21-8. PubMed ID: 12203364
[TBL] [Abstract][Full Text] [Related]
18. Activation of protein kinase C betaII/epsilon-c-Jun NH2-terminal kinase pathway and inhibition of mitogen-activated protein/extracellular signal-regulated kinase 1/2 phosphorylation in antitumor invasive activity induced by the polymethoxy flavonoid, nobiletin.
Miyata Y; Sato T; Yano M; Ito A
Mol Cancer Ther; 2004 Jul; 3(7):839-47. PubMed ID: 15252145
[TBL] [Abstract][Full Text] [Related]
19. Extracellular signal-regulated kinase (ERK) activity is required for TPA-mediated inhibition of drug-induced apoptosis.
Stadheim TA; Kucera GL
Biochem Biophys Res Commun; 1998 Apr; 245(1):266-71. PubMed ID: 9535820
[TBL] [Abstract][Full Text] [Related]
20. Insulin-induced c-Jun N-terminal kinase activation is negatively regulated by protein kinase C delta.
Morino K; Maegawa H; Fujita T; Takahara N; Egawa K; Kashiwagi A; Kikkawa R
Endocrinology; 2001 Jun; 142(6):2669-76. PubMed ID: 11356718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
